Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 390

1.

Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks.

Maron RC, Weichenthal M, Utikal JS, Hekler A, Berking C, Hauschild A, Enk AH, Haferkamp S, Klode J, Schadendorf D, Jansen P, Holland-Letz T, Schilling B, von Kalle C, Fröhling S, Gaiser MR, Hartmann D, Gesierich A, Kähler KC, Wehkamp U, Karoglan A, Bär C, Brinker TJ; Collabrators.

Eur J Cancer. 2019 Aug 13;119:57-65. doi: 10.1016/j.ejca.2019.06.013. [Epub ahead of print]

2.

Accumulation of 'Old Proteins' and the Critical Need for Mass Spectrometry based Protein Turnover Measurements in Aging and Longevity.

Basisty N, Holtz A, Schilling B.

Proteomics. 2019 Aug 13:e1800403. doi: 10.1002/pmic.201800403. [Epub ahead of print] Review.

PMID:
31408259
3.

Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data.

Sondermann W, Utikal JS, Enk AH, Schadendorf D, Klode J, Hauschild A, Weichenthal M, French LE, Berking C, Schilling B, Haferkamp S, Fröhling S, von Kalle C, Brinker TJ.

Eur J Cancer. 2019 Aug 8;119:30-34. doi: 10.1016/j.ejca.2019.07.009. [Epub ahead of print]

4.

Deep neural networks are superior to dermatologists in melanoma image classification.

Brinker TJ, Hekler A, Enk AH, Berking C, Haferkamp S, Hauschild A, Weichenthal M, Klode J, Schadendorf D, Holland-Letz T, von Kalle C, Fröhling S, Schilling B, Utikal JS.

Eur J Cancer. 2019 Aug 8;119:11-17. doi: 10.1016/j.ejca.2019.05.023. [Epub ahead of print]

5.

Post-translational Protein Acetylation: An Elegant Mechanism for Bacteria to Dynamically Regulate Metabolic Functions.

Christensen DG, Xie X, Basisty N, Byrnes J, McSweeney S, Schilling B, Wolfe AJ.

Front Microbiol. 2019 Jul 12;10:1604. doi: 10.3389/fmicb.2019.01604. eCollection 2019. Review.

6.

Breaking Avelumab Resistance with combined Ipilimumab and Nivolumab in Metastatic Merkel Cell Carcinoma?

Glutsch V, Kneitz H, Goebeler M, Gesierich A, Schilling B.

Ann Oncol. 2019 Jul 26. pii: mdz230. doi: 10.1093/annonc/mdz230. [Epub ahead of print] No abstract available.

PMID:
31350554
7.

On the Accuracy of Factory-Calibrated Low-Cost Soil Water Content Sensors.

Domínguez-Niño JM, Bogena HR, Huisman JA, Schilling B, Casadesús J.

Sensors (Basel). 2019 Jul 13;19(14). pii: E3101. doi: 10.3390/s19143101.

8.

Response to combined ipilimumab and nivolumab after development of a nephrotic syndrome related to PD-1 monotherapy.

Glutsch V, Grän F, Weber J, Gesierich A, Goebeler M, Schilling B.

J Immunother Cancer. 2019 Jul 12;7(1):181. doi: 10.1186/s40425-019-0655-4.

9.

Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma.

Kreft S, Gesierich A, Eigentler T, Franklin C, Valpione S, Ugurel S, Utikal J, Haferkamp S, Blank C, Larkin J, Garbe C, Schadendorf D, Lorigan P, Schilling B.

Eur J Cancer. 2019 Jul;116:207-215. doi: 10.1016/j.ejca.2019.05.015. Epub 2019 Jun 15.

PMID:
31212163
10.

High-Resolution Mass Spectrometry to Identify and Quantify Acetylation Protein Targets.

Schilling B, Meyer JG, Wei L, Ott M, Verdin E.

Methods Mol Biol. 2019;1983:3-16. doi: 10.1007/978-1-4939-9434-2_1.

PMID:
31087289
11.

Chemoirradiated neutrophils and T cells differentially affect immune functions of APCs.

Franklin C, Bruderek K, Schilling B, Brandau S.

J Leukoc Biol. 2019 Aug;106(2):481-493. doi: 10.1002/JLB.5A0618-242R. Epub 2019 May 10.

PMID:
31075186
12.

Noncaseating granulomatous diseases in germ cell cancer patients-A single-center experience.

Schmidt LH, Huss S, Schuelke C, Schulze A, Evers G, Schliemann C, Hansmeier A, Schilling B, Lauterbach B, Barth P, Wiebe K, Goerlich D, Berdel WE, Puehse G, Mohr M.

Urol Oncol. 2019 Aug;37(8):531.e17-531.e25. doi: 10.1016/j.urolonc.2019.03.010. Epub 2019 Apr 30.

PMID:
31053525
13.

Regulation of UCP1 and Mitochondrial Metabolism in Brown Adipose Tissue by Reversible Succinylation.

Wang G, Meyer JG, Cai W, Softic S, Li ME, Verdin E, Newgard C, Schilling B, Kahn CR.

Mol Cell. 2019 May 16;74(4):844-857.e7. doi: 10.1016/j.molcel.2019.03.021. Epub 2019 Apr 15.

PMID:
31000437
14.

Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task.

Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, Haferkamp S, Schadendorf D, Holland-Letz T, Utikal JS, von Kalle C; Collaborators.

Eur J Cancer. 2019 May;113:47-54. doi: 10.1016/j.ejca.2019.04.001. Epub 2019 Apr 10.

15.

Mechanisms, Detection, and Relevance of Protein Acetylation in Prokaryotes.

Christensen DG, Baumgartner JT, Xie X, Jew KM, Basisty N, Schilling B, Kuhn ML, Wolfe AJ.

MBio. 2019 Apr 9;10(2). pii: e02708-18. doi: 10.1128/mBio.02708-18. Review.

16.

Correction for Christensen et al., "Identification of Novel Protein Lysine Acetyltransferases in Escherichia coli".

Christensen DG, Meyer JG, Baumgartner JT, D'Souza AK, Nelson WC, Payne SH, Kuhn ML, Schilling B, Wolfe AJ.

MBio. 2019 Apr 9;10(2). pii: e00592-19. doi: 10.1128/mBio.00592-19. No abstract available.

17.

A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task.

Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, Haferkamp S, Schadendorf D, Fröhling S, Utikal JS, von Kalle C; Collaborators.

Eur J Cancer. 2019 Apr;111:148-154. doi: 10.1016/j.ejca.2019.02.005. Epub 2019 Mar 8.

18.

VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People.

Henderson LM, Robinson RF, Ray L, Khan BA, Li T, Dillard DA, Schilling BD, Mosley M, Janssen PL, Fohner AE, Rettie AE, Thummel KE, Thornton TA, Veenstra DL.

Clin Transl Sci. 2019 May;12(3):312-320. doi: 10.1111/cts.12611. Epub 2019 Mar 1.

19.

JNK modifies neuronal metabolism to promote proteostasis and longevity.

Wang L, Davis SS, Borch Jensen M, Rodriguez-Fernandez IA, Apaydin C, Juhasz G, Gibson BW, Schilling B, Ramanathan A, Ghaemmaghami S, Jasper H.

Aging Cell. 2019 Jun;18(3):e12849. doi: 10.1111/acel.12849. Epub 2019 Feb 27.

20.

First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis.

Schilling B, Martens A, Geukes Foppen MH, Gebhardt C, Hassel JC, Rozeman EA, Gesierich A, Gutzmer R, Kähler KC, Livingstone E, Diamantopoulos PT, Gogas H, Madonna G, Ascierto PA, Goldinger SM, Mangana J, Garbe C, Schadendorf D, Blank C, Weide B.

Cancer Immunol Immunother. 2019 May;68(5):765-772. doi: 10.1007/s00262-019-02311-1. Epub 2019 Feb 26.

PMID:
30806748
21.

Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark.

Brinker TJ, Hekler A, Hauschild A, Berking C, Schilling B, Enk AH, Haferkamp S, Karoglan A, von Kalle C, Weichenthal M, Sattler E, Schadendorf D, Gaiser MR, Klode J, Utikal JS.

Eur J Cancer. 2019 Apr;111:30-37. doi: 10.1016/j.ejca.2018.12.016. Epub 2019 Feb 22.

22.

Global Lysine Acetylation in Escherichia coli Results from Growth Conditions That Favor Acetate Fermentation.

Schilling B, Basisty N, Christensen DG, Sorensen D, Orr JS, Wolfe AJ, Rao CV.

J Bacteriol. 2019 Apr 9;201(9). pii: e00768-18. doi: 10.1128/JB.00768-18. Print 2019 May 1.

PMID:
30782634
23.

Adipose Stem Cells Enhance Nerve Regeneration and Muscle Function in a Peroneal Nerve Ablation Model.

Passipieri JA, Dienes J, Frank J, Glazier J, Portell A, Venkatesh KP, Bliley JM, Grybowski D, Schilling BK, Marra KG, Christ GJ.

Tissue Eng Part A. 2019 May 23. doi: 10.1089/ten.TEA.2018.0244. [Epub ahead of print]

PMID:
30760135
24.

Injectable Allograft Adipose Matrix Supports Adipogenic Tissue Remodeling in the Nude Mouse and Human.

Kokai LE, Schilling BK, Chnari E, Huang YC, Imming EA, Karunamurthy A, Khouri RK, D'Amico RA, Coleman SR, Marra KG, Rubin JP.

Plast Reconstr Surg. 2019 Feb;143(2):299e-309e. doi: 10.1097/PRS.0000000000005269.

25.

Adipose-derived stem cells delay muscle atrophy after peripheral nerve injury in the rodent model.

Schilling BK, Schusterman MA 2nd, Kim DY, Repko AJ, Klett KC, Christ GJ, Marra KG.

Muscle Nerve. 2019 May;59(5):603-610. doi: 10.1002/mus.26432. Epub 2019 Feb 20.

PMID:
30681163
26.

Solid phase microextraction Arrow for the determination of synthetic musk fragrances in fish samples.

Castro Ó, Trabalón L, Schilling B, Borrull F, Pocurull E.

J Chromatogr A. 2019 Apr 26;1591:55-61. doi: 10.1016/j.chroma.2019.01.032. Epub 2019 Jan 11.

PMID:
30658910
27.

Tackling melanoma by adjuvant therapy: why, whom and how?

Schilling B, Wiesner T.

Br J Dermatol. 2019 Jan;180(1):1-2. doi: 10.1111/bjd.17039. No abstract available.

PMID:
30604551
28.

Temporal dynamics of liver mitochondrial protein acetylation and succinylation and metabolites due to high fat diet and/or excess glucose or fructose.

Meyer JG, Softic S, Basisty N, Rardin MJ, Verdin E, Gibson BW, Ilkayeva O, Newgard CB, Kahn CR, Schilling B.

PLoS One. 2018 Dec 26;13(12):e0208973. doi: 10.1371/journal.pone.0208973. eCollection 2018.

29.

The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas.

Appenzeller S, Gesierich A, Thiem A, Hufnagel A, Jessen C, Kneitz H, Regensburger M, Schmidt C, Zirkenbach V, Bischler T, Schilling B, Siedel C, Goebeler ME, Houben R, Schrama D, Gehrig A, Rost S, Maurus K, Bargou R, Rosenwald A, Schartl M, Goebeler M, Meierjohann S.

Cancer. 2019 Feb 15;125(4):586-600. doi: 10.1002/cncr.31843. Epub 2018 Dec 18.

PMID:
30561760
30.

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.

Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su MJ, Melms JC, Leeson R, Kanodia A, Mei S, Lin JR, Wang S, Rabasha B, Liu D, Zhang G, Margolais C, Ashenberg O, Ott PA, Buchbinder EI, Haq R, Hodi FS, Boland GM, Sullivan RJ, Frederick DT, Miao B, Moll T, Flaherty KT, Herlyn M, Jenkins RW, Thummalapalli R, Kowalczyk MS, Cañadas I, Schilling B, Cartwright ANR, Luoma AM, Malu S, Hwu P, Bernatchez C, Forget MA, Barbie DA, Shalek AK, Tirosh I, Sorger PK, Wucherpfennig K, Van Allen EM, Schadendorf D, Johnson BE, Rotem A, Rozenblatt-Rosen O, Garraway LA, Yoon CH, Izar B, Regev A.

Cell. 2018 Nov 1;175(4):984-997.e24. doi: 10.1016/j.cell.2018.09.006.

PMID:
30388455
31.

Identification of Novel Protein Lysine Acetyltransferases in Escherichia coli.

Christensen DG, Meyer JG, Baumgartner JT, D'Souza AK, Nelson WC, Payne SH, Kuhn ML, Schilling B, Wolfe AJ.

MBio. 2018 Oct 23;9(5). pii: e01905-18. doi: 10.1128/mBio.01905-18. Erratum in: MBio. 2019 Apr 9;10(2):.

32.

Identifying ubiquitinated proteins and aggregates.

Basisty N, Schilling B, Rabinovitch PS.

Aging (Albany NY). 2018 Oct 18;10(10):2549-2550. doi: 10.18632/aging.101605. No abstract available.

33.

Programmed death-1 blockade for multiple basal cell carcinomas: clearing the field systemically?

Haug V, Schilling B.

Br J Dermatol. 2018 Sep;179(3):566-567. doi: 10.1111/bjd.16991. No abstract available.

PMID:
30222888
34.

Evolution of melanoma cross-resistance to CD8+ T cells and MAPK inhibition in the course of BRAFi treatment.

Pieper N, Zaremba A, Leonardelli S, Harbers FN, Schwamborn M, Lübcke S, Schrörs B, Baingo J, Schramm A, Haferkamp S, Seifert U, Sucker A, Lennerz V, Wölfel T, Schadendorf D, Schilling B, Paschen A, Zhao F.

Oncoimmunology. 2018 Apr 18;7(8):e1450127. doi: 10.1080/2162402X.2018.1450127. eCollection 2018.

35.

Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors.

Miao D, Margolis CA, Vokes NI, Liu D, Taylor-Weiner A, Wankowicz SM, Adeegbe D, Keliher D, Schilling B, Tracy A, Manos M, Chau NG, Hanna GJ, Polak P, Rodig SJ, Signoretti S, Sholl LM, Engelman JA, Getz G, Jänne PA, Haddad RI, Choueiri TK, Barbie DA, Haq R, Awad MM, Schadendorf D, Hodi FS, Bellmunt J, Wong KK, Hammerman P, Van Allen EM.

Nat Genet. 2018 Sep;50(9):1271-1281. doi: 10.1038/s41588-018-0200-2. Epub 2018 Aug 27.

36.

Impairment of Angiogenesis by Fatty Acid Synthase Inhibition Involves mTOR Malonylation.

Bruning U, Morales-Rodriguez F, Kalucka J, Goveia J, Taverna F, Queiroz KCS, Dubois C, Cantelmo AR, Chen R, Loroch S, Timmerman E, Caixeta V, Bloch K, Conradi LC, Treps L, Staes A, Gevaert K, Tee A, Dewerchin M, Semenkovich CF, Impens F, Schilling B, Verdin E, Swinnen JV, Meier JL, Kulkarni RA, Sickmann A, Ghesquière B, Schoonjans L, Li X, Mazzone M, Carmeliet P.

Cell Metab. 2018 Dec 4;28(6):866-880.e15. doi: 10.1016/j.cmet.2018.07.019. Epub 2018 Aug 23.

PMID:
30146486
37.

Preclinical Optimization of a Shelf-Ready, Injectable, Human-Derived, Decellularized Allograft Adipose Matrix.

Giatsidis G, Succar J, Haddad A, Lago G, Schaffer C, Wang X, Schilling B, Chnari E, Matsumine H, Orgill DP.

Tissue Eng Part A. 2019 Feb;25(3-4):271-287. doi: 10.1089/ten.TEA.2018.0052. Epub 2018 Oct 16.

PMID:
30084731
38.

Simultaneous Quantification of the Acetylome and Succinylome by 'One-Pot' Affinity Enrichment.

Basisty N, Meyer JG, Wei L, Gibson BW, Schilling B.

Proteomics. 2018 Sep;18(17):e1800123. doi: 10.1002/pmic.201800123. Epub 2018 Aug 19.

39.

Nocardiosis in a patient with anti-PD-1-associated colitis treated with infliximab.

Glutsch V, Gesierich A, Goebeler M, Forster J, Schilling B.

Eur J Cancer. 2018 Sep;101:284-286. doi: 10.1016/j.ejca.2018.06.014. Epub 2018 Jul 13. No abstract available.

PMID:
30017385
40.

Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade.

Milsch L, Gesierich A, Kreft S, Livingstone E, Zimmer L, Goebeler M, Schadendorf D, Schilling B.

Eur J Cancer. 2018 Aug;99:58-65. doi: 10.1016/j.ejca.2018.05.012. Epub 2018 Jun 12.

PMID:
29906735
41.

Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations.

Kugel CH 3rd, Douglass SM, Webster MR, Kaur A, Liu Q, Yin X, Weiss SA, Darvishian F, Al-Rohil RN, Ndoye A, Behera R, Alicea GM, Ecker BL, Fane M, Allegrezza MJ, Svoronos N, Kumar V, Wang DY, Somasundaram R, Hu-Lieskovan S, Ozgun A, Herlyn M, Conejo-Garcia JR, Gabrilovich D, Stone EL, Nowicki TS, Sosman J, Rai R, Carlino MS, Long GV, Marais R, Ribas A, Eroglu Z, Davies MA, Schilling B, Schadendorf D, Xu W, Amaravadi RK, Menzies AM, McQuade JL, Johnson DB, Osman I, Weeraratna AT.

Clin Cancer Res. 2018 Nov 1;24(21):5347-5356. doi: 10.1158/1078-0432.CCR-18-1116. Epub 2018 Jun 13.

42.

Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors.

Thiem A, Schummer P, Ueberschaar S, Kerstan A, Kneitz H, Schrama D, Appenzeller S, Meierjohann S, Schilling B, Goebeler M, Gesierich A.

Melanoma Res. 2018 Oct;28(5):465-468. doi: 10.1097/CMR.0000000000000458.

PMID:
29781871
43.

Pembrolizumab-associated mucous membrane pemphigoid in a patient with Merkel cell carcinoma.

Haug V, Behle V, Benoit S, Kneitz H, Schilling B, Goebeler M, Gesierich A.

Br J Dermatol. 2018 Oct;179(4):993-994. doi: 10.1111/bjd.16780. Epub 2018 Jul 23. No abstract available.

PMID:
29758087
44.

Biodegradable silk catheters for the delivery of therapeutics across anatomical repair sites.

Brown JE, Tozzi L, Schilling B, Kelmendi-Doko A, Truong AB, Rodriguez MJ, Gil ES, Sucsy R, Valentin JE, Philips BJ, Marra KG, Rubin JP, Kaplan DL.

J Biomed Mater Res B Appl Biomater. 2019 Apr;107(3):501-510. doi: 10.1002/jbm.b.34140. Epub 2018 Apr 26.

PMID:
29697188
46.

Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.

Shukla SA, Bachireddy P, Schilling B, Galonska C, Zhan Q, Bango C, Langer R, Lee PC, Gusenleitner D, Keskin DB, Babadi M, Mohammad A, Gnirke A, Clement K, Cartun ZJ, Van Allen EM, Miao D, Huang Y, Snyder A, Merghoub T, Wolchok JD, Garraway LA, Meissner A, Weber JS, Hacohen N, Neuberg D, Potts PR, Murphy GF, Lian CG, Schadendorf D, Hodi FS, Wu CJ.

Cell. 2018 Apr 19;173(3):624-633.e8. doi: 10.1016/j.cell.2018.03.026. Epub 2018 Apr 12.

47.

Removing 4E-BP Enables Synapses to Refine without Postsynaptic Activity.

Chong Y, Saviuk N, Pie B, Basisty N, Quinn RK, Schilling B, Sonenberg N, Cooper E, Haghighi AP.

Cell Rep. 2018 Apr 3;23(1):11-22. doi: 10.1016/j.celrep.2018.03.040.

48.

NF1 mutations in conjunctival melanoma.

Scholz SL, Cosgarea I, Süßkind D, Murali R, Möller I, Reis H, Leonardelli S, Schilling B, Schimming T, Hadaschik E, Franklin C, Paschen A, Sucker A, Steuhl KP, Schadendorf D, Westekemper H, Griewank KG.

Br J Cancer. 2018 May;118(9):1243-1247. doi: 10.1038/s41416-018-0046-5. Epub 2018 Mar 21.

49.

Panorama Public: A Public Repository for Quantitative Data Sets Processed in Skyline.

Sharma V, Eckels J, Schilling B, Ludwig C, Jaffe JD, MacCoss MJ, MacLean B.

Mol Cell Proteomics. 2018 Jun;17(6):1239-1244. doi: 10.1074/mcp.RA117.000543. Epub 2018 Feb 27.

50.

Kinetic and Electromyographic Subphase Characteristics With Relation to Countermovement Vertical Jump Performance.

Harry JR, Paquette MR, Schilling BK, Barker LA, James CR, Dufek JS.

J Appl Biomech. 2018 Aug 1;34(4):291-297. doi: 10.1123/jab.2017-0305. Epub 2018 Jul 3.

PMID:
29485344

Supplemental Content

Loading ...
Support Center